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Abstract
Candida albicans causes candidiasis, secretes farnesol, and switches from yeast to
hyphae to escape from macrophages after phagocytosis. However, before escape,
macrophages may respond to C. albicans’ pathogen-associated molecular patterns
(PAMPs) through toll-like receptor 2 (TLR2) and dectin-1 receptors by expressing
cytokines involved in adaptive immunity, inflammation, and immune regulation.
Therefore, macrophages and the RAW264.7 macrophage line were challenged with
C. albicans preparations of live wild-type cells, heat-killed cells, a live mutant
defective in hyphae formation, a live mutant producing less farnesol, or an isolate
producing farnesoic acid instead of farnesol. Interleukin-6 (IL-6), and IL-1b, IL-
10, and tumor necrosis factor-a (TNF-a) expression were evaluated by ELISA and/
or qRT-PCR within 6 h after challenge. All viable strains producing farnesol,
regardless of hyphae phenotype, induced IL-6, IL-1b, IL-10, and TNF-a. To
determine which components of C. albicans induced IL-6, RAW264.7 cells were
incubated with farnesol, farnesoic acid, with or without zymosan, a yeast cell wall
preparation that contains PAMPs recognized by TLR2 and dectin-1. The highest
expression of IL-6, TLR2, and dectin-1 occurred when RAW264.7 cells were
stimulated with zymosan and farnesol together. Our results suggest that the rapid
expression of cytokines from macrophages challenged with C. albicans is due to
cell-wall PAMPs combined with farnesol.
Introduction
Candida albicans is a commensal fungus that colonizes the
human oral cavity and intestine. It is polymorphic in that it
converts between yeast, hyphal, and pseudohyphal forms
(Berman, 2006). Individuals with healthy immune systems
limit Candida growth at mucosal sites. In contrast, a com-
promised immune system often leads to mucocandidiasis,
oral thrush, or systemic candidiasis, with significant mortal-
ity (Klein et al., 1984; Launay et al., 1998; Pfaller & Diekema,
2007). Key virulence factors leading to mucosal or systemic
candidiasis include the following: (1) cell morphogenesis,
i.e. yeast to hyphae switching; (2) phenotypic switching, for
example white to opaque switching; (3) epithelial adhesion;
(4) extracellular enzymes, for example phospholipase B
and aspartyl proteases; and (5) production of farnesol
(Navarathna et al., 2005, 2007a, b). Farnesol was first
identified as a quorum-sensing molecule (QSM) in that it
blocked the yeast to hyphae conversion by C. albicans
(Hornby et al., 2001). Later, we showed that farnesol also
acted as a virulence factor (Navarathna et al., 2005, 2007a, b).
At that time, we created a knockout mutation in DPP3,
the gene encoding one of the two phosphatases that converts
farnesyl pyrophosphate to farnesol. This mutant KWN2
(dpp3/dpp3), which had only one of the phosphatases,
produced six times less farnesol and was c. 4.2 times less
pathogenic to mice than its parent (Navarathna et al.,
2007a b). We also created the DPP3 reconstituted strain
(KWN4) such that it regained the mutated farnesyl pyropho-
sphatases, expressed both farnesyl pyrophosphatases, and as a
result regained complete farnesol production and pathogeni-
city (Navarathna et al., 2007a).
Since that time, we have been interested in farnesol’s
mode of action as a virulence factor. This mode of action
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appears to be distinct from farnesol’s mode of action as a
QSM, i.e. blocking hyphal development. As a step toward
deciphering farnesol’s mode of action, we showed that blood
from mice pretreated with farnesol had significantly reduced
levels of both the critical Th1 cytokine interferon-g (IFN-g)
and the Th1-inducing cytokine interleukin-12 (IL-12),
accompanied by elevated Th2 cytokine IL-5 (Navarathna
et al., 2007a, b).
In addition to farnesol production, C. albicans conversion
from yeast to hyphal forms is also a virulence factor. We have
shown that following ingestion by macrophages, wild-type
C. albicans turns on arginine biosynthesis, metabolizes that
arginine via arginase (CAR1) and urea amidolyase (DUR1,2)
to activate the yeast to hyphae switch, and escapes from
the macrophage (Ghosh et al., 2009). Wild-type C. albicans
escaped within 4–6 h, whereas both arginine auxotrophs and
dur1,2/dur1,2 mutants were unable to form hyphae or
escape (Ghosh et al., 2009). A critical unanswered question
concerns the extent to which macrophages are able to
produce cytokines before they are killed.
Macrophages are known to produce cytokines that promote
inflammation, others that direct CD41 T cell differentiation to
a phenotype that promotes effective immunity to C. albicans,
and others that regulate inflammation and adaptive immu-
nity. Macrophage IL-1b and tumor necrosis factor-a (TNF-a)
promote inflammation by increasing chemokine production
and the expression of endothelial cell adhesion molecules.
Macrophage IL-12 directs T cell differentiation to the Th1
subset that produces IFN-g, which in turn activates macro-
phages (Nathan et al., 1983). We have shown previously that
farnesol decreases the expression of IL-12 from macrophages
(Navarathna et al., 2007b). Alternately, macrophage IL-6 is
pivotally involved in the development of the Th17 (Bettelli
et al., 2006) subset, which produces IL-17 that is required for
resistance against mucosal (Conti et al., 2009) and systemic
candidiasis (Huang et al., 2004). The production of IL-17 leads
to the accumulation of neutrophils (Huang et al., 2004), which
effectively phagocytize and kill both yeast and hyphal versions
of C. albicans (Rubin-Bejerano et al., 2003). However, IL-6 is
also involved in systemic inflammation and may play a role in
pathogenesis when produced in excessive amounts (Cuzzocrea
et al., 1999). Therefore, C. albicans induction of IL-6 from
macrophages plays a role in the development of both innate
and adaptive immunity, as well as in its systemic virulence.
However, it is still unclear whether macrophages that have
phagocytized C. albicans express IL-6 before their death.
To mediate cytokine responses to C. albicans, monocytes,
macrophages, and dendritic cells express 11 leucine-rich
toll-like receptors (TLRs) and c-type lectins such as dectin-
1, which recognize distinctive pathogen-associated molecu-
lar patterns (PAMPs) (Hume et al., 2001; Jones et al., 2001;
Netea et al., 2008). Cell surface TLR2 responds to C. albicans
whole cells, zymosan (an Saccharomyces cerevisiae cell-wall-
derived preparation that contains b-glucans as a major
component, and also mannan and chitin), as well as to
phospholipomannans of C. albicans (Jouault et al., 2003),
while TLR4 responds to C. albicans a-mannans (Tada et al.,
2002). Indeed, TLR2 is essential for resistance against
systemic infection against C. albicans (Villamon et al.,
2004). However, TLR2 is not alone in its response to
zymosan and C. albicans cells as dectin-1 binds to b-glucan
(Brown et al., 2002) and associates with TLR2 to provide a
collaborative response to C. albicans (Goodridge et al.,
2007). Therefore, TLR2 and dectin-1 are key macrophage
cell surface molecules for responses to C. albicans.
The present paper takes a further step in elucidating
farnesol’s mode of action. These experiments are carried out
with the same C. albicans/murine macrophage system that we
used to show the importance of arginine biosynthesis by
C. albicans (Ghosh et al., 2009). We have adopted a genetic
and molecular approach to examine whether postphagocytic
hyphae formation and/or farnesol production influence the
ability of macrophages to express IL-6 and other cytokines. In
this report, we used five strains of C. albicans that are
defective in hyphae formation or farnesol production to
determine the impact of these fungal virulence factors on the
postphagocytic induction of IL-6, as well as IL-1b, IL-10, and
TNF-a. We show that following phagocytosis of C. albicans by
macrophages, the expression of IL-6, IL-1b, TNF-a, and
IL-10 was rapidly induced regardless of whether those cells
were capable of hyphae formation or maximal farnesol
production. Using farnesol, farnesoic acid, and zymosan,
alone or in combination, we found that farnesol and zymosan
act synergistically to induce IL-6 from macrophages.
Materials and methods
Strains, media, growth conditions, and
chemicals
The C. albicans wild-type SC5314, which can form germ tubes
and produce farnesol, and strain SN152 (URA3/ura3<imm434
his1/his1 arg4/arg4 leu2/leu2 IRO1/iro1<imm436) (Noble &
Johnson, 2005), which is defective in germ tube formation
(GTF), but can induce farnesol, were obtained from Dr
Alexander Johnson, University of California at San Francisco.
Candida albicans 10231, which is a clinical isolate that forms
germ tubes, but produces farnesoic acid instead of farnesol,
was obtained from the American Type Culture Collection
(Rockville, MD). The construction of KWN2 (dpp3<
C.d.HIS1/dpp3<C.m.LEU2, his1/his1, leu2/leu2, arg4/arg4),
which produces low farnesol, and KWN4 (dpp3<DPP3/
dpp3<DPP3, his1/his1, leu2/leu2, arg4/arg4), which produces
normal farnesol, from the parental strain SN152 was described
previously (Navarathna et al., 2007a, b). Thus, SN152 and
KWN4 do not produce germ tubes, but do produce farnesol,
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while KWN2 does not produce germ tubes and produces low
farnesol. Otherwise, SN152, KWN2, and the reconstructed
KWN4 are isogenic strains.
Candida albicans strains were grown and maintained in
YPD medium (10 g of yeast extract, 5 g of peptone and 20 g
of glucose per liter) at 30 1C, while auxotrophic mutants
were grown in YPD supplemented with 40mg mL1 of
required amino acid. Resting-phase cells were grown over-
night in YPD at 30 1C, washed three times with 50 mM
potassium phosphate buffer, and stored in the same
buffer. These cells were used for co-culture with murine
macrophage RAW264.7 line. Heat-killed (HK) cells were
prepared by heating the resting-phase cells at 60 1C for 2 h.
This temperature regime was chosen to ensure that the
C. albicans cells were still intact particles, suitable for
phagocytosis. Cell death was confirmed by spreading the
HK cells on YPD plates; there was no growth following
incubation at 30 1C for 24 h (data not shown). The murine
RAW264.7 macrophage-like cell line was grown in a com-
plete culture medium consisting of Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine
serum (FBS) plus 50 mg mL1 gentamicin at 37 1C in the
presence of 5% CO2.
The trans, trans-farnesol was purchased from Sigma-
Aldrich Chemicals, St. Louis, MO, (E, E)farnesoic acid from
Echelon Biosciences Inc., Salt Lake City, UT, and zymosan
from InVivogen, San Diego, CA. Farnesol and farnesoic acid
were dissolved in methanol while zymosan was suspended in
ethanol to prepare stock solutions before use.
Preparation of splenic macrophages and
challenge with C. albicans
Spleens from C57Bl/6 mice were extracted under aseptic
conditions and cells were gently dispersed using 90 mesh
screens into cold cell culture media (CCM) that contained
DMEM (Sigma-Aldrich Chemicals), 50mg mL1 gentami-
cin, and 10% FBS. The cell suspensions were centrifuged
at 500g at 4 1C for 10 min. Erythrocytes were lysed with
Gey’s reagent for 5 min, and then the remaining cells were
washed twice with CCM. The viability and concentration of
mononuclear cells were determined using trypan blue and a
hemacytometer. Adherent splenic macrophages were ob-
tained by adjusting mononuclear cells to 107 per 2 mL of
CCM in six-well culture dishes and incubating overnight
at 37 1C in 5% CO2/air. Nonadherent cells were removed
from by adding 37 1C-warmed CCM, swirling, and then
aspirating away suspended cells. In 2 mL of CCM, adherent
splenic macrophages were unstimulated or stimulated with
106 viable SN152, KWN2, or KWN4 C. albicans cells,
based on optimal stimulation determined from preliminary
assays. After 6 h of stimulation, the supernatants were
collected.
Challenge of RAW264.7 cells with C. albicans or
their components
We, and many others, have shown that the RAW264.7 cell line
expresses similar levels of cytokines compared with splenic
macrophages in response to several pattern-recognition recep-
tor (PRR) agonists (Kollet et al., 2001; Al-Salleeh & Petro,
2008). Therefore, RAW264.7 cells were stimulated with
C. albicans, zymosan, or farnesol. One day before the experi-
ment, RAW264.7 cells that reached confluence in culture
media were collected, washed, and counted using a hemacyt-
ometer. Cells (105) per well were plated in culture media in 12-
well plates and grown overnight in 5% CO2 at 37 1C to allow
adherence to the surface. On day 0, the nonadherent cells were
removed from the plates by aspiration and a fresh prewarmed
complete culture medium was added. Resting-phase C. albi-
cans cells were washed with phosphate-buffered saline (PBS)
and their concentrations were measured using a Spectronic 20
spectrophotometer. Cells (4 105) were added to each well
(4 : 1 C. albicans : macrophage ratio based on optimal stimula-
tion from preliminary assays), and the plates were incubated
for 1, 2, or 3 h in 5% CO2 at 37 1C. For the challenge of
RAW264.7 cells with various C. albicans components, cells
were treated with: (a) 5mM of farnesol; (b) 250mM of farnesoic
acid; (c) 25mg mL1 of zymosan; (d) 5mM of farnesol and
25mg mL1 of zymosan or in one experiment 0.1–20mM of
farnesol and 25mg mL1 of zymosan; (e) 250mM of farnesoic
acid and 25mg mL1 of zymosan; (f) 5mM of farnesol and
4 105 HK SC5314 cells; or (g) 250mM of farnesoic acid and
4 105 HK SC5314 cells. After 1, 2, and 3 h, the supernatants
were removed for enzyme-linked immunosorbent assay (ELI-
SA), 400mL of lysing buffer (5Prime PerfectPure RNA Cell and
Tissue, RNA isolation kit) was added to the cells, and the
sample was transferred into tubes and frozen at  80 1C.
RNA isolation, cDNA, and reverse transcriptase
(RT)-PCR
RNA was extracted using the PerfectPure RNA isolation kit of
5Prime Inc. (Gaithersburg, MD) according to the manufac-
turer’s instructions. cDNAs were prepared from 0.3mg of
RNA. Quantitative real-time RT-PCR (qRT-PCR) was carried
out in the presence of 1 mM dNTPs, 2mM MgCl2, 2 U Taq
DNA polymerase, 1mM of each primer, and 1mL of cDNA
in 25mL. For IL-6, IL-1b, TNF-a, IL-10, dectin-1, TLR2,
and GAPDH, qRT-PCR was performed using the Platinum-
SYBR Green I-UDG-quantitative PCR SuperMix (Invitrogen)
and the following primers: IL-6, 50-ATGAAGTTCCTCTCTG
CAAGAGACT-30/50-CACTAGGTTTGCCGAGTAGATCTC-30
(638 bp); IL-1b, 50-AACTGTTCCTGAACTCAACTGT-30/50-
GAGATTTGAAGCTGGATGCTCT-30 (150 bp); TNF-a, 50-CA
TGATCCGCGACGTGGAACTG-30/50-AGAGGGAGGCCATT
TGGGAACT-30 (195 bp); IL-10, 50-ATGCAGGACTTTAAGG
GTTACTTGGGTG-30/50-ATTTCGGAGAGAG GTACAAACG
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AGGTTT-30 (455 bp); dectin-1, 50-AGAGAATCTGGATGAAG
ATGGA-30/50-ACCACAAAGCACAGGATTCCTA-30 (150 bp);
TLR2, 50-TCTAAAGTCGATCCGCGACAT-30/50-TACCCAGC
TCGCTCACTACGT-30 (344 bp); and GAPDH, 50-TTGTCAG
CAATGCATCCTGCAC-30/50-ACAGCTTTCCAGAGGGGCC
ATC-30 (149 bp). qRT-PCR reactions were run on an ABI
Prism 7000 thermal cycler in which 1mL of cDNA was
incubated at 50 1C for 2 min, 95 1C for 10 min, followed by 40
cycles of 95 1C for 15 s and 60 1C for 30 s. Cycle thresholds (Ct)
were normalized to Ct for GAPDH for each cDNA and
expressed by fold increase using the formula: 2DDCt , where
DD= (the difference between the Ct value obtained from
cytokine/PRR cDNA of stimulated samples and the Ct value
obtained from GAPDH cDNA of stimulated samples)  (the
difference between the average Ct of cytokine/PRR of unstimu-
lated samples and the average Ct value obtained from GAPDH
cDNA of unstimulated samples).
ELISA
Mouse IL-6 was quantified by coating 96-well assay plates with
2mg mL1 purified unconjugated anti-IL-6 monoclonal anti-
body (clone MP5-20F3) in bicarbonate buffer (pH 9.6) at 4 1C
overnight. After two washes with PBS/0.05% Tween 20
(Sigma-Aldrich Chemicals), the plate was blocked with PBS/
10% FBS. For the standard curve, serial dilutions of recombi-
nant IL-6 (Pharmingen) were added to wells coated with
respective anti-IL-6. The plate was incubated at room tem-
perature for 2 h. After washing two times with PBS/Tween 20,
the plate was incubated with 2mg mL1 biotinylated anti-IL-6
(clone MP5-32C11) in PBS/10% FBS at room temperature for
45 min. After six washes with PBS/Tween 20, the plates were
incubated with dilute (1 : 1000) streptavidin peroxidase (Sig-
ma-Aldrich Chemicals) at room temperature for 30 min. The
plates were washed five times with PBS/Tween 20 and
incubated with 3, 30, 5, 50 tetramethylbenzidine substrate/
hydrogen peroxide solution and readings were taken at
OD450 nm wavelength with a reference of OD570 nm using an
ELISA spectrophotometric plate reader.
Statistical analysis
Cytokine expression measured by PCR and cytokine pro-
duction measured by ELISA was analyzed using Student’s
t-test to determine the significance of differences; P-values of
 0.05 were considered significant.
Results
Yeast--hyphae dimorphism plays no role in the
induction of IL-6 by C. albicans
Because C. albicans escapes from macrophage following
phagocytosis, there are few reports describing macrophage
cytokine expression following C. albicans challenge. We
decided to measure IL-6 expression by macrophages chal-
lenged with C. albicans and identify the cellular components
in C. albicans that might be responsible for inducing IL-6.
Splenic macrophages were challenged with live C. albicans
SN152 (normal farnesol), KWN2 (low farnesol), and KWN4
(restored farnesol production) for 6 h and IL-6 production
was measured using ELISA. This time frame was chosen
because in this system wild-type C. albicans cells form germ
tubes and escape 4–6 h after ingestion (Ghosh et al., 2009).
Figure 1a shows that splenic macrophages rapidly (within 6 h)
produced significantly more (2–3.5 times over the back-
ground) IL-6 in response to the challenge with C. albicans
than unchallenged splenic macrophages. Similar results were
obtained with strain SN152 and the two mutants of SN152
that produce altered levels of farnesol (Fig. 1a).
We have seen that the RAW264.7 macrophage cell line in
response to various TLR agonists expresses cytokines at
levels equivalent to primary splenic macrophages (Kollet
et al., 2001; Al-Salleeh & Petro, 2008). Therefore, the
response of RAW264.7 cells to five strains of C. albicans was
explored by measuring IL-6 mRNA, by qRT-PCR, for 3 h
after challenge (Fig. 1b). Wild-type C. albicans SC5314
rapidly induced the macrophage expression of IL-6. Note that
the IL-6 scale is logarithmic and thus the expression of IL-6
mRNA increased almost 1000-fold by 3 h. This indication of
enhanced IL-6 gene expression was confirmed by measure-
ment of the actual IL-6 protein from RAW264.7 cells. The
supernatants of RAW264.7 cells phagocytizing C. albicans
SC5314 were evaluated by ELISA for secreted IL-6. At 6 h,
RAW264.7 cells that had phagocytized SC5314 secreted sig-
nificantly more (8.7 times) IL-6 compared with those that had
not (13.07 1.42 vs. 1.5 0.21 pg mL1, P = 0.001).
Like SC5314, C. albicans SN152, KWN2, and KWN4,
which are all arginine auxotrophs and thus defective in GTF
and escape from macrophages (Ghosh et al., 2009), induced
1000-fold increases in IL-6 expression by RAW264.7 cells
(Fig. 1b). Interestingly, strain 10231, which undergoes GTF,
but generates farnesoic acid instead of farnesol (Oh et al.,
2001; Hornby & Nickerson, 2004) (vide infra), failed to
induce IL-6 expression from RAW264.7 cells (Fig. 1b).
Likewise, IL-6 expression in response to HK SC5314, which
cannot produce farnesol de novo, was substantially less than
that for live SC5314 (Fig. 1b). Similarly, SC5314, SN152,
KWN2, and KWN4 induced RAW264.7 cells to produce
roughly equivalent levels of IL-1b, IL-10, and TNF-a within
3 h (Fig. 2). In contrast to IL-6 expression, C. albicans that
underwent GTF were unable to express significant levels of
IL-23 and transforming growth factor-b (TGF-b), two other
cytokines that contribute to Th17 development, within 3 h
(data not shown), while mutant C. albicans that are defective
in GTF induced low, but detectable IL-23 and TGF-b mRNA
within 3 h (data not shown).
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Farnesol stimulates the expression of IL-6 from
macrophages
Four strains of C. albicans were chosen to determine
whether the level of farnesol production influenced cytokine
production, either positively or negatively. Strain 10231 is a
wild-type strain, capable of GTF and escape from macro-
phages (Ghosh et al., 2009), but it is unusual because it
produces farnesoic acid (Oh et al., 2001) rather than farnesol
Fig. 1. Splenic macrophages (a) and RAW264.7 cells (b) express IL-6 in
response to challenge by Candida albicans. (a) IL-6 protein production by
splenic macrophages after 6 h or (b) real-time qRT-PCR of mRNA expression
in RAW264.7 cells after 1, 2, and 3 h. A total of 1 107 splenic mono-
nuclear cells or 1 105 RAW264.7 cells in culture media were seeded
overnight in CCM. Adherent splenic macrophages were given PBS (Uns) or
challenged with 1106 SN152, KWN2, or KWN4 cells, while RAW264.7
cells were control or challenged with 4 105 cells of SC5314 (wild type),
HK SC5314 (HKSC5314), 10231 (wild-type clinical isolate) that secretes
farnesoic acid instead of farnesol, SN152 (URA3/ura3<imm434 his1/his1
arg4/arg4 leu2/leu2 IRO1/iro1<imm436) – defective in GTF inside macro-
phages, but secretes farnesol similar to the wild type; or KWN2
(dpp3<C.d.HIS1/dpp3<C.m.LEU2, his1/his1, leu2/leu2, arg4/arg4) – de-
fective in GTF inside macrophages and secretes six times less farnesol
compared with the wild type; or KWN4 (dpp3<DPP3/dpp3<DPP3, his1/
his1, leu2/leu2, arg4/arg4) – defective in GTF inside macrophages and
secrete two times more farnesol compared with the wild type; dissolved in
PBS for 1, 2, and 3 h. (a) Bar graphs represent mean IL-6 SEM (n = 5) as
measured by ELISA and (b) Bar graphs represent the mean relative
induction of IL-6 mRNA SEM (n = 3) as measured by qRT-PCR of three
independent experiments normalized to GAPDH expression; Mean is
significantly different from the control, Po 0.05.
Fig. 2. RAW264.7 cells express inflammatory cytokines IL-1b (a), TNF-a
(b), and immunoregulatory cytokine IL-10 (c) in response to a challenge
by Candida albicans. Real-time qRT-PCR of IL-1b (a), TNF-a (b), and IL-10
(c) mRNA in RAW264.7 cells after 3 h. A total of 1 105 RAW264.7 cells
in culture media were given PBS (Uns) or challenged with 4 105 (MOI
4 : 1) cells of SC5314 (wild type), SN152, KWN2, or KWN4 in PBS for 3 h.
Bar graphs represent the mean relative induction SEM (n = 4) normal-
ized to GAPDH; Mean is significantly different from the control,
Po 0.05.
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(Hornby & Nickerson, 2004). KWN2 is a dpp3/dpp3 mutant
that produces only 15% as much farnesol as its parent
SN152 due to a defect in one of the pathways for the
conversion of farnesyl pyrophosphate to farnesol (Navar-
athna et al., 2007a, b). Both DPP3 and farnesol production
were reconstituted in KWN4 (Navarathna et al., 2007a, b).
Thus, strains SN152, KWN2, and KWN4 are isogenic and
they are all derived from SC5314. Figure 1b shows that
strains SN152, KWN2, and KWN4 all increased IL-6 expres-
sion c. 1000-fold, just like the wild-type clinical isolate
SC5314. In contrast, strain 10231 and HK SC5314 elicited
only background levels of IL-6 expression (Fig. 1b).
Farnesol and zymosan synergistically induce IL-6
expression
The results so far suggest that farnesol, perhaps in conjunc-
tion with another component of C. albicans cells, induces
IL-6 expression by macrophages. Zymosan, a yeast cell wall
preparation containing b-glucan, is a likely candidate for a
fungal component that could synergize with farnesol to
induce cytokines from macrophages. b-1,3-Glucan, a major
cell wall component of zymosan, as well as S. cerevisiae and
C. albicans cell walls, is known to stimulate cytokine expres-
sion by binding to dectin-1 (Ozinsky et al., 2000; Brown et al.,
2002, 2003), a receptor that collaborates with TLR2 (Sato
et al., 2003) in stimulating synergistic signaling pathways.
Accordingly, we next examined which combinations of
zymosan with farnesol or farnesoic acid induced high levels
of IL-6 expression by the RAW264.7 cell line (Fig. 3).
Zymosan, farnesol, or farnesoic acid by themselves failed to
stimulate the expression of IL-6 (Fig. 3). Interestingly, farne-
sol or farnesoic acid significantly decreased the background
expression of IL-6 from RAW264.7 cells (Fig. 3). However, the
combination of zymosan and farnesol induced significant
expression of IL-6. This combination of two cellular compo-
nents yielded levels of IL-6 mRNA expression similar to those
induced by whole cells of SC5314, SN152, KWN2, or KWN4
(Fig. 1). The combination of farnesoic acid and zymosan, to
some extent, also stimulated IL-6 expression, even though
strain 10231 failed to do so. It is likely that strain 10231 only
excretes very low levels of farnesoic acid in the first 3 h after
phagocytosis. As we noted above, the 15% farnesol produced
by KWN2 is apparently sufficient for the induction of IL-6
expression from macrophages. To confirm this notion, we
stimulated RAW264.7 cells with zymosan plus varying farne-
sol concentrations. The data indicated that zymosan and
farnesol at 1/50th of the original concentration induced as
much IL-6 expression from RAW264.7 cells as zymosan plus
the original concentration of farnesol or zymosan plus four
times more farnesol (data not shown). Therefore, KWN2
produces enough farnesol for the synergistic induction of
IL-6 expression from the RAW264.7 line.
The combination of farnesol and zymosan
stimulates the expression of dectin-1
We and others have shown that the RAW264.7 cells consti-
tutively express TLR2 (Al-Salleeh & Petro, 2007), but low
levels of dectin-1 (Taylor et al., 2002; Brown et al., 2003).
However, the expressions of both TLR2 and dectin-1 can be
stimulated further when macrophages encounter microor-
ganisms. We hypothesize that the synergism of zymosan and
farnesol is associated with the increased expression of TLR2
and/or dectin-1 induced by zymosan or farnesol. Therefore,
RAW264.7 cell expression of TLR2 and dectin-1 was deter-
mined by qRT-PCR following stimulation with zymosan,
farnesol, farnesoic acid, or combinations of farnesol plus
zymosan or farnesoic acid plus zymosan. The expression of
TLR2 was significantly stimulated by zymosan alone, while
farnesol plus zymosan did not increase this expression
further (Fig. 4a). In contrast, farnesoic acid did not increase
the expression of TLR2, either with or without zymosan. In
contrast to TLR2 expression, the expression of dectin-1 was
significantly enhanced only with the combination of zymo-
san and farnesol (Fig. 4b). Zymosan alone, farnesol alone, or
farnesoic acid alone or in combination with zymosan failed
to stimulate the expression of dectin-1 further in RAW264.7
cells. Therefore, the synergism of zymosan and farnesol in
Fig. 3. RAW264.7 cytokine expression in response to the challenge by
yeast cell components. Real-time qRT-PCR of IL-6 in RAW264.7 cells. A
total of 1 105 RAW264.7 cells were incubated with 5 mL of methanol
(control); farnesol (5 mM); farnesoic acid (250mM); zymosan
(25 mg mL1); farnesol (5 mM) and zymosan (25 mg mL1) together; farne-
soic acid (250 mM) and zymosan (25 mg mL1) together; HK SC5314
(4 105) and farnesol (5 mM) together; or HK SC5314 (4 105) and
farnesoic acid (250mM) together for 3 h. Farnesol and farnesoic acid
were dissolved in 5 mL of methanol. Bar graphs represent mean SEM
(n = 3) of three independent experiments normalized to GAPDH; Mean
is significantly different from the control, Po 0.05. FOH, farnesol;
FCOOH, farnesoic acid; Zymo, zymosan; HK, heat-killed SC5314 cells.
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the induction of IL-6 expression is related to increased
expression of dectin-1.
Discussion
We showed previously (Ghosh et al., 2009) that those
macrophages that have phagocytized C. albicans die within
4–6 h because the fungal pathogen converts to hyphae inside
the phagosome, pierces the phagosomic and cytoplasmic
membranes, and escapes. Here, we show that splenic macro-
phages produce and the RAW264.7 murine macrophage cell
line expresses critical cytokines within 3–6 h after phagocy-
tosis of the fungus C. albicans. Furthermore, macrophages
that phagocytized hyphal-forming C. albicans (SC5314)
expressed nearly as much cytokines as macrophages that
phagocytized mutants of C. albicans (SN152) that do not
form hyphae. Thus, GTF and hyphal growth are not
necessary for the expression of IL-6 or the other macrophage
cytokines within 3 h after challenge with C. albicans. These
results show that macrophages that have phagocytized
C. albicans can, before they are killed by escaping C. albicans,
express substantial amounts of IL-6 (Bettelli et al., 2006;
Korn et al., 2008), IL-1b and TNF-a for inflammation
(Tonnesen, 1989), and IL-10 for immune regulation (Ed-
wards et al., 2006). Furthermore, whether or not the
C. albicans undergo GTF after phagocytosis does not affect
the expression of these cytokines within 3 h. Therefore,
C. albicans escape from macrophages does not alter the early
kinetics of cytokine expression. This rapid time frame for
the expression of these cytokines is essential for macro-
phages’ participation in the development of inflammation,
adaptive immunity, and immune regulation. Therefore,
macrophages that phagocytize C. albicans, despite their
inability to kill this fungal pathogen, can potentially trans-
mit cytokine signals that contribute toward the development
of effective antifungal adaptive immunity, inflammation, and
immune regulation. Among the cytokines expressed by
macrophages in response to C. albicans is IL-6, which, in
conjunction with TGF-b and IL-23, is essential for the
induction of Th17 (Bettelli et al., 2006; Ivanov et al., 2007).
Th17 in turn secretes IL-17 and IL-22 (Liang et al., 2006),
which play pivotal roles in anti-Candida immunity (Huang
et al., 2004) through the induction of defensins from epithe-
lial cells (Liang et al., 2006), some of which are candidacidal.
In addition, IL-17 is critical to the accumulation of neutro-
phils at the site of Candida infection (Liang et al., 2007). We
also show here that macrophages that phagocytize C. albicans
also express IL-1b and TNF-a, two cytokines that are also
critical for the inflammatory response leading to neutrophil
accumulation at infected sites (Tonnesen, 1989). Neutrophils
play the pivotal role in anti-Candida immunity because,
unlike macrophages, they are capable of phagocytizing and
killing C. albicans (Rubin-Bejerano et al., 2003). In addition
to inflammatory cytokines, macrophages that phagocytize
C. albicans also express the cytokine IL-10 within 3 h. IL-10
is important in control of the inflammation (Mosser &
Edwards, 2008) induced by C. albicans infection (Del Sero
et al., 1999). However, IL-10 may significantly impair resis-
tance against systemic infection with C. albicans that leads to
infection in the kidney (Vazquez-Torres et al., 1999). There-
fore, phagocytosis of C. albicans by macrophages, which
cannot effectively kill the fungus, stimulates the expression
of cytokines from macrophages that contribute to inflamma-
tion and immune regulation.
Of interest is the observation that in contrast to live
C. albicans, HK C. albicans failed to induce IL-6 expression
Fig. 4. RAW264.7 TLR2 and dectin-1 expression in response to the
challenge by yeast cell components. Real-time qRT-PCR of TLR2 (a) and
dectin-1 (b) in RAW264.7 cells. A total of 1 105 RAW264.7 cells were
incubated with 5 mL of methanol (Uns); farnesol (5 mM); farnesoic acid
(250 mM); zymosan (25 mg mL1); farnesol (5 mM) and zymosan
(25 mg mL1) together; and farnesoic acid (250mM) and zymosan
(25 mg mL1) together for 3 h. Bar graphs represent mean SEM (n = 4)
normalized to GAPDH; Mean is significantly different from the control,
Po 0.05. FOH, farnesol; FCOOH, farnesoic acid; Zymo, zymosan.
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within 3 h. Gow et al. (2007) showed that HK C. albicans,
which exposes more b-glucan than live C. albicans, does
induce IL-6 production from macrophages. However, their
measurement of induced IL-6 production by HK C. albicans
occurred at 24–48 h after exposure to macrophages. There-
fore, significant early induction of IL-6 production from
macrophages by HK C. albicans does not occur.
It is also clear from this report that two components of
viable C. albicans are responsible for stimulating these
cytokines from macrophages. One of the components is
farnesol, a QSM and virulence factor excreted by C. albicans
(Hornby et al., 2001), and the other is zymosan, which
contains yeast cell wall components such as b-1,3-glucan,
chitin, and mannans. It is known that zymosan stimulates
macrophages through TLR2 acting in collaboration with
dectin-1 (Goodridge et al., 2007) or TLR6 (Hajjar et al.,
2001). TLR2 is also known to dimerize with TLR1 (Hajjar
et al., 2001) and galectin-3 (Jouault et al., 2006). However,
dectin-1 has been shown to be critical to antifungal im-
munity (Taylor et al., 2007; Robinson et al., 2009), and
dectin-1 and TLR2 synergistically induce the expression of
cytokines from macrophages (Ferwerda et al., 2008). Never-
theless, future experiments will need to sort out which of the
dimer partners of TLR2 and which cell wall components of
C. albicans participate in the heightened expression of the
aforementioned cytokines from macrophage following pha-
gocytosis. Previous reports, measuring cytokines at 24
and 48 h, have shown that zymosan (Dillon et al., 2006)
and farnesol (Decanis et al., 2009), acting separately, can
induce the expression of IL-6. The present report shows that
farnesol alone can decrease the background expression of
IL-6 from macrophages, while zymosan and farnesol, acting
together, can induce the expression of IL-6 within 3 h. The
results presented here are clinically relevant because the
innate immune response to zymosan also induces aseptic
shock, multiorgan failure, and death in the host (Cuzzocrea
et al., 1997), probably due to excess production of zymosan-
induced IL-6 (Cuzzocrea et al., 1999). However, here, we
show that farnesol and zymosan, acting together within 3 h,
induce greater expression of IL-6 from macrophages than
either of those two factors alone. Therefore, the combina-
tion of zymosan and farnesol may induce macrophages to
generate IL-6, one of the cytokines necessary for the devel-
opment of Th17, a T cell subset essential for immunity to
C. albicans (Huang et al., 2004; Conti et al., 2009). This
combination also induces cytokines such as TNF-a, which,
along with IL-6, are involved in shock and death following
systemic infection.
In addition to IL-6, IL-23 and TGF-b also contribute to
Th17 development. However, macrophages that phagocytize
C. albicans that produced hyphae were unable to express
significant levels of IL-23 and TGF-b within 3 h (data not
shown). In contrast, macrophages that phagocytize mutant
C. albicans that do not produce hyphae express low, but
detectable IL-23 and TGF-b mRNA within 3 h (data not
shown). Further studies will be needed to understand the
receptor and signaling system activated for the macrophage
response to farnesol. We suggest that farnesol enhances the
effect of cell wall PAMPs of C. albicans on macrophage
cytokine expression. It should be noted that while IL-6 is
important in murine induction of Th17, IL-1b is the
corresponding macrophage cytokine for the development
of Th17 in humans (Acosta-Rodriguez et al., 2007). Here, we
show in a murine macrophage cell line that C. albicans
induces IL-1b 1278-fold within 3 h after phagocytosis. These
results suggest that human macrophages phagocytizing
C. albicans may also express the additional Th17-inducing
cytokine, IL-1b.
In general, HK C. albicans induced far less early expres-
sion of cytokines compared with the live wild-type
C. albicans cells. HK cells, which are likely to be phagocy-
tized by macrophages, are inactive metabolically and there-
fore cannot produce farnesol or hyphae. In contrast, live
C. albicans, which are phagocytized by macrophages, switch
their morphology from yeast to hyphae, produce farnesol,
kill the macrophage, and escape. Neither C. albicans 10 231
nor HK SC5314 caused increased IL-6 expression (Fig. 1a).
Although strain 10 231 is of a different genetic background,
it is a useful strain for comparison because it is the only
known isolate of C. albicans that does not secrete farnesol.
Therefore, farnesol, but not farnesoic acid, likely plays a role
in IL-6 expression by macrophages. Presumably, the 15%
farnesol produced by KWN2 (Navarathna et al., 2007a, b) is
sufficient for whatever role farnesol plays in the macrophage
because the IL-6 expression levels by SN152, KWN2, and
KWN4 were equivalent (Fig. 1a and b). Therefore, active
farnesol production by C. albicans, in combination with cell
wall components after phagocytosis, is likely necessary for
high IL-6 expression from macrophages, whereas farnesol
alone appears to decrease the expression of IL-6 from
macrophages. Similarly, hyphae formation in the phago-
some is not required, but does not prevent cytokine expres-
sion because equivalent levels of IL-6 expression were
stimulated by the wild-type SC5314 and the three arginine
auxotrophs, which do not produce hyphae.
Our long-term goal is to discern the role of farnesol in
pathogenicity and virulence. In doing so, we must reconcile
four quite different modes of action for farnesol. Farnesol
was first discovered as a QSM for C. albicans (Hornby et al.,
2001). That is, in vitro C. albicans produced and excreted
farnesol, and when the farnesol concentration exceeded a
threshold level, it prevented the yeast to hypha switch. Next,
in the present paper, we found that farnesol, together with
cell wall components, acts as a signal to elicit the production
of cytokines from macrophages. This suggests that farnesol
is a costimulator of PAMPs within the cell wall. However,
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whole animal studies showed that farnesol acts instead as a
virulence factor. Candida albicans mutants that produced
sixfold less farnesol were c. fourfold less virulent (Navar-
athna et al., 2007a) and wild-type C. albicans that had been
treated with sublethal levels of fluconazole, thus producing
8–12 times more farnesol (Hornby & Nickerson, 2004;
Navarathna et al., 2005, 2007a), were c. sixfold more virulent
(Navarathna et al., 2005, 2007a). Our data in Fig. 3 indicate
that farnesol alone without costimulation with cell wall
components could decrease IL-6 expression, thus fulfilling
its role as a virulence factor. It is also possible that the high
level of inflammatory cytokines induced by farnesol in
synergism with cell wall components in vitro is lethal during
systemic candidiasis. Additionally, we found that farnesol
significantly reduced the mouse serum levels of IFN-g and
IL-12 during systemic candidiasis (Navarathna et al.,
2007b), which could prove to enhance virulence because
both of these cytokines are needed for optimum immunity
to C. albicans. Further study will be needed to connect these
observations. For now, farnesol’s exact mode of action as a
virulence factor or a costimulator of PAMPs remains elusive.
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